Hersi Ahmad
Department of Cardiac Sciences, College of Medicine, King Saud University, Riyadh, KSA.
J Atr Fibrillation. 2012 Jun 15;5(1):413. doi: 10.4022/jafib.413. eCollection 2012 Jun-Jul.
The association between obstructive sleep apnea (OSA) and cardiovascular disease is well known. Data from most studies investigating the prevalence of OSA in atrial fibrillation (AF), and of AF in patients with OSA, have supported the relationship between these common diseases. In addition, several studies have shown a detrimental effect of OSA on AF treatment. These reports vary considerably in methodology, and are particularly diverse in their definitions and diagnosis of OSA and patient populations studied. Considering these studies individually while exploring their methodological variations and the range of results achieved can reinforce the necessity of establishing standards for performing this important research. Reviewing these studies should en courage practitioners to reflect on how the methodologies, patients, and outcomes are relevant to their practices.
阻塞性睡眠呼吸暂停(OSA)与心血管疾病之间的关联众所周知。大多数研究阻塞性睡眠呼吸暂停在心房颤动(AF)中的患病率以及阻塞性睡眠呼吸暂停患者中心房颤动患病率的数据,都支持了这两种常见疾病之间的关系。此外,多项研究表明阻塞性睡眠呼吸暂停对房颤治疗有不利影响。这些报告在方法上差异很大,在阻塞性睡眠呼吸暂停的定义、诊断以及所研究的患者群体方面尤其多样。在探索其方法学差异和所取得的结果范围时单独考虑这些研究,可以强化为开展这项重要研究制定标准的必要性。回顾这些研究应促使从业者思考这些方法、患者和结果与他们的实践有何关联。